home
about us
member log-in
contact us

PRODUCTS
MUNICIPAL BONDS
INDEX FUNDS
- Total Asset Fund (TAF)
EVENTS
MARKET RESEARCH

Recent Quotes

View Full List

My Watchlist

Indicators

Markets:

Overview

News

Currencies

International

Treasuries

ANI Pharmaceuticals, Inc. - Common Stock (NQ:ANIP)

79.88 -0.12 (-0.15%)

Streaming Delayed Price Updated: 4:00 PM EST, Feb 3, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about ANI Pharmaceuticals, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9 Next >

ANI Pharmaceuticals Appoints Krista Davis as Chief Human Resources Officer

September 12, 2022

From ANI Pharmaceuticals, Inc.

Via Business Wire

Benzinga's Top Ratings Upgrades, Downgrades For September 7, 2022 ↗

September 07, 2022

Upgrades

Via Benzinga

ANI Pharmaceuticals to Present at the H.C. Wainwright 24th Annual Global Investment Conference

August 30, 2022

From ANI Pharmaceuticals, Inc.

Via Business Wire

ANI Pharmaceuticals: Q2 Earnings Insights ↗

August 08, 2022

ANI Pharmaceuticals (NASDAQ:ANIP) reported its Q2 earnings results on Monday, August 8, 2022 at 06:50 AM. Here's what investors need to know about the announcement.

Via Benzinga

ANI Pharmaceuticals: Q1 Earnings Insights ↗

May 10, 2022

ANI Pharmaceuticals (NASDAQ:ANIP) reported its Q1 earnings results on Tuesday, May 10, 2022 at 06:50 AM. Here's what investors need to know about the announcement.

Via Benzinga

ANI Pharmaceuticals Announces the Launch of Prochlorperazine Maleate Tablets USP

August 29, 2022

From ANI Pharmaceuticals, Inc.

Via Business Wire

Recap Of Tuesday's Biotech Catalysts - End Of the Day Summary ↗

August 16, 2022

Via Benzinga

12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗

August 16, 2022

Via Benzinga

ANI Pharmaceuticals Announces FDA Approval and Imminent Launch of Dexamethasone Tablets USP

August 16, 2022

From ANI Pharmaceuticals, Inc.

Via Business Wire

ANI Pharmaceuticals Reports Second Quarter 2022 Financial Results; Reports Record Net Revenues and Raises Full-Year 2022 Net Revenue Guidance for Purified Cortrophin® Gel

August 08, 2022

From ANI Pharmaceuticals, Inc.

Via Business Wire

ANI Pharmaceuticals Announces the Launch of Acebutolol Hydrochloride Capsules USP

August 03, 2022

From ANI Pharmaceuticals, Inc.

Via Business Wire

ANI Pharmaceuticals Acquires ANDAs from Oakrum Pharma, LLC

July 28, 2022

From ANI Pharmaceuticals, Inc.

Via Business Wire

ANI Pharmaceuticals to Discuss Second Quarter 2022 Financial Results on August 8, 2022, at 8:00 a.m. ET

July 25, 2022

From ANI Pharmaceuticals, Inc.

Via Business Wire

ANI Pharmaceuticals Appoints Meredith W. Cook as SVP, General Counsel and Corporate Secretary

July 18, 2022

From ANI Pharmaceuticals, Inc.

Via Business Wire

ANI Pharmaceuticals Announces FDA Approval and Imminent Launch of Clorazepate Dipotassium Tablets USP

June 22, 2022

From ANI Pharmaceuticals, Inc.

Via Business Wire

ANI Pharmaceuticals's Return On Capital Employed Overview ↗

June 08, 2022

According to data from Benzinga Pro, during Q1, ANI Pharmaceuticals's (NASDAQ:ANIP) reported sales totaled $64.48 million. Despite a 16.6% increase in earnings, the company posted a loss of $20.13...

Via Benzinga

ANI Pharmaceuticals Announces Consolidation of Manufacturing Network, Capturing Operational Synergies Post Novitium Acquisition

June 02, 2022

From ANI Pharmaceuticals, Inc.

Via Business Wire

ANI Pharmaceuticals Announces the FDA Approval and Imminent Launch of Fludrocortisone Acetate Tablets USP

June 01, 2022

From ANI Pharmaceuticals, Inc.

Via Business Wire

ANI Pharmaceuticals to Present at Upcoming Healthcare Investor Conferences

May 20, 2022

From ANI Pharmaceuticals, Inc.

Via Business Wire

ANI Pharmaceuticals Reports First Quarter 2022 Results; Provides Purified Cortrophin® Gel Net Revenue Guidance and Full-Year 2022 Total Company Net Revenue Guidance of $295 Million to $315 Million

May 10, 2022

From ANI Pharmaceuticals, Inc.

Via Business Wire

ANI Pharmaceuticals Q1 2022 Earnings Conference Call On May 10, 2022 At 08:30 AM ET ↗

May 06, 2022

ANI Pharmaceuticals (NASDAQ:ANIP) will host a conference call at 08:30 AM ET on May 10, 2022, to discuss Q1 2022 earnings results.

Via Benzinga

ANI Pharmaceuticals to Discuss First Quarter 2022 Financial Results on May 10, 2022

April 19, 2022

From ANI Pharmaceuticals, Inc.

Via Business Wire

ANI Pharmaceuticals Announces the Launch of Misoprostol Tablets

April 11, 2022

From ANI Pharmaceuticals, Inc.

Via Business Wire

Insider Weekends: Return Of The Meme Stocks - GameStop (GME) And AMC Entertainment (AMC) ↗

March 28, 2022

Via Benzinga

ANI Pharmaceuticals Appoints Experienced Commercial Leader, Renee P. Tannenbaum, Pharm.D., MBA, to Board of Directors

March 22, 2022

From ANI Pharmaceuticals, Inc.

Via Business Wire

ANI Pharmaceuticals's Return On Capital Employed Insights ↗

March 16, 2022

ANI Pharmaceuticals (NASDAQ:ANIP) brought in sales totaling $60.93 million during Q4 according to data provided by Benzinga Pro. However, earnings decreased 442.75%, resulting in...

Via Benzinga

68 Biggest Movers From Yesterday ↗

March 16, 2022

Gainers Sonim Technologies, Inc. (NASDAQ: SONM) shares jumped 103.3% to settle at $1.22 on Tuesday after the company announced its XP8 smartphone has integrated with the Walkie...

Via Benzinga

Mid-Afternoon Market Update: Nasdaq Rises Over 200 Points; ANI Pharmaceuticals Shares Slide ↗

March 15, 2022

U.S. stocks traded higher toward the end of trading, with the Dow Jones gaining 350 points on Tuesday. The Dow traded up 1.07% to 33,297.32 while the NASDAQ rose 1.81% to 12,809....

Via Benzinga

12 Health Care Stocks Moving In Tuesday's Intraday Session ↗

March 15, 2022

Gainers Incannex Healthcare (NASDAQ:IXHL) stock rose 164.2% to $60.5 during Tuesday's regular session. Incannex Healthcare's stock is trading at a volume of 664.5K...

Via Benzinga

Upbeat Inflation Data, Falling Oil Prices Prop Up Dow ↗

March 15, 2022

Wall Street is eyeing an upbeat session, with the Dow Jones Industrial Average up 377 points at midday.

Via Talk Markets

< Previous 1 2 3 4 5 6 7 8 9 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Home
About Us
Products
Municipal Bonds
Index Funds
Seminars & Events
Market Research
Contact Us
Member Section
Privacy Policy
Terms & Conditions
Security Notice
Customer Service

Securities offered through Purshe Kaplan Sterling Investments, member FINRA / SIPC, Headquartered at 80 State Street,
Albany, NY 12207
Purshe Kaplan Sterling Investments and Tamar Securities, LLC are not affiliated companies.
Tamar Securities, LLC is a Registered Investment Adviser. Advisory services are only offered to clients or prospective clients where Tamar Securities, LLC
and its representatives are properly licensed or exempt from licensure. Past performance is no guarantee of future returns. Investing involves risk and possible loss of principal capital.
No advice may be rendered by Tamar Securities, LLC unless a client service agreement is in place.

NOT FDIC INSURED. NOT BANK GUARANTEED. MAY LOSE VALUE, INCLUDING LOSS OF PRINCIPAL. NOT INSURED BY ANY STATE OR FEDERAL AGENCY.
Web development by IBCnet.com